We have studied the antiferromagnetic Ising chain in a transverse magnetic field hx and uniform longitudinal field hz. Using the density matrix renormalization group calculation combined with a finite-size scaling the ground state phase diagram in (hx, hz) plane is determined. It is shown that there is an order-disordered transition line in this plane and the critical properties belong to the universality class of the two-dimensional Ising model. Based on the perturbation theory in hz the scaling behavior of the mass gap in the vicinity of the critical point (hx = 1/2, hz = 0) is established. It is found that the form of the transition line near the classical multicritical point (hx = 0, hz = 1) is linear. The connection of the considered quantum model with the quasi-one-dimensional classical Ising model in the magnetic field is discussed.
We report magnetic-susceptibility, specific-heat, and Raman-scattering investigations of ␣-TeVO 4 containing V-O edge-sharing chains. These chains promote a system of ferromagnetic/antiferromagnetic spin-1/2 Heisenberg alternating exchange chains with pronounced spin frustration. The magnetic susceptibility and Raman scattering evidence a crossover at T ء = 85 K with different slopes of the reciprocal susceptibility and a magnetic phase transition into a long-range-ordered state at T c = 16 K. From Raman-scattering data a strong mutual coupling between lattice and magnetic degrees of freedom is deduced. A comparison to model calculations and prior Raman scattering on other chain systems yields a plausible interpretation of the microscopic mechanism for the crossover behavior.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.